Nazila Habibizad Global Blood Therapeutics, Inc. (GBT) insider trading activity

Nazila Habibizad is Officer of Global Blood Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GBT, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2022, when has been sold 39,680 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Nazila Habibizad Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 05 2022	SELL Sale (or disposition) back to the issuer	-	39,680 Reduced 100.0%	0 Common Stock
Oct 01 2022	BUY Exercise of conversion of derivative security	-	1,557 Added 3.78%	39,680 Common Stock
Sep 29 2022	SELL Bona fide gift	-	3,500 Reduced 8.41%	38,123 Common Stock
Sep 27 2022	BUY Exercise of conversion of derivative security	$1,176,810 $39.55 p/Share	29,755 Added 41.69%	41,623 Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$91,457 $68.15 p/Share	1,342 Reduced 10.16%	11,868 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	3,878 Added 22.69%	13,210 Common Stock
Aug 31 2022	BUY Grant, award, or other acquisition	$10,503 $25.37 p/Share	414 Added 4.25%	9,332 Common Stock
Aug 18 2022	SELL Open market or private sale	$314,315 $67.19 p/Share	4,678 Reduced 34.41%	8,918 Common Stock
Aug 01 2022	SELL Payment of exercise price or tax liability	$17,042 $32.4 p/Share	526 Reduced 3.72%	13,596 Common Stock
Aug 01 2022	BUY Exercise of conversion of derivative security	-	1,518 Added 9.71%	14,122 Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$19,391 $35.91 p/Share	540 Reduced 1.77%	30,036 Common Stock
Apr 01 2022	BUY Exercise of conversion of derivative security	-	1,558 Added 4.85%	30,576 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$18,310 $29.87 p/Share	613 Reduced 2.07%	29,018 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	1,671 Added 5.34%	29,631 Common Stock

Nazila Habibizad

Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBT shares.

Notify only if

Value

Insider Trading

Get notified when an Global Blood Therapeutics, Inc. insider buys or sells GBT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Global Blood Therapeutics, Inc.

Track Activities on GBT

Account